Eli Lilly
LLY
LLY
1,365 hedge funds and large institutions have $71.1B invested in Eli Lilly in 2018 Q2 according to their latest regulatory filings, with 121 funds opening new positions, 426 increasing their positions, 543 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.03% more ownership
Funds ownership: 76.86% → 76.89% (+0.03%)
6% less call options, than puts
Call options by funds: $368M | Put options by funds: $392M
22% less repeat investments, than reductions
Existing positions increased: 426 | Existing positions reduced: 543
Holders
1,365
Holding in Top 10
23
Calls
$368M
Puts
$392M
Top Buyers
| 1 | +$442M | |
| 2 | +$293M | |
| 3 | +$105M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$105M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$91.9M |
Top Sellers
| 1 | -$358M | |
| 2 | -$279M | |
| 3 | -$259M | |
| 4 |
Goldman Sachs
New York
|
-$142M |
| 5 |
Two Sigma Investments
New York
|
-$107M |